rebound weight gain after semaglutide Stopping Semaglutide, Ozempic and Wegovy What really happens to your
Description
The primary endpoint was the percentage weight loss at six months (M6) compared to baseline
In participants with obesity and chronic kidney disease without diabetes, once-weekly administration of semaglutide 2.4mg led to a reduction in albuminuria, body weight and systolic blood pressure compared with placebo, with no changes to creatinine or cystatin-C estimated glomerular filtration rate or measured glomerular filtration rate during the 24-week follow-up period.
Although lipid profiles, HbA1c, and FBG were unaffected, GLP-1 RA was linked to a slight reduction in SBP (SMD 0.20
Big news
Discover Ozempic in Kenya weight loss programs
Tested on all skin types and tones
